Esketamine Attenuates Postoperative Neurocognitive Disorder in Aged Mice: Associations with Bioenergetic Remodeling in Hippocampal CD11b-Enriched Cell Fractions and Glycolysis-Related Signaling
Di Liu, Guangchun Li, Hui Huang, Yong Yang, Fei Jiang, Yue Zhang · 2026
Read Esketamine Attenuates Postoperative Neurocognitive Disorder in Aged Mice: Associations with Bioenergetic Remodeling in Hippocampal CD11b-Enriched Cell Fractions and Glycolysis-Related Signaling by Di Liu, Guangchun Li, Hui Huang, Yong Yang, Fei Jiang, Yue Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13525777.txt.
Description
Di Liu and five co-authors study a drug that may ease thinking problems after surgery in older patients, using aged mice in a 2026 paper. Surgery can leave older people with lasting trouble in learning and memory, and brain immune cells play a part. The team ask whether the drug esketamine calms that immune response and restores cell energy use in the hippocampus.
Mice given the drug learned and remembered better, and an early spike in a key inflammation signal was lower. Cells rich in an immune marker showed lower sugar burning and better energy output in their power centers. A drug that blocks sugar burning gave some like effects, hinting at a shared path.
Catalog record
| CREATOR | Di Liu, Guangchun Li, Hui Huang, Yong Yang, Fei Jiang, Yue Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |